GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Cyclically Adjusted PB Ratio

Betta Pharmaceuticals Co (SZSE:300558) Cyclically Adjusted PB Ratio : 7.41 (As of Jun. 04, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Betta Pharmaceuticals Co's current share price is ¥61.78. Betta Pharmaceuticals Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ¥8.34. Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio for today is 7.41.

The historical rank and industry rank for Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

SZSE:300558' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.38   Med: 6.38   Max: 7.18
Current: 6.83

During the past years, Betta Pharmaceuticals Co's highest Cyclically Adjusted PB Ratio was 7.18. The lowest was 5.38. And the median was 6.38.

SZSE:300558's Cyclically Adjusted PB Ratio is ranked worse than
88.65% of 696 companies
in the Drug Manufacturers industry
Industry Median: 1.975 vs SZSE:300558: 6.83

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Betta Pharmaceuticals Co's adjusted book value per share data for the three months ended in Mar. 2025 was ¥13.176. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥8.34 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Betta Pharmaceuticals Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Cyclically Adjusted PB Ratio Chart

Betta Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 6.67

Betta Pharmaceuticals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 5.74 6.67 6.14

Competitive Comparison of Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio falls into.


;
;

Betta Pharmaceuticals Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=61.78/8.34
=7.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Betta Pharmaceuticals Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Betta Pharmaceuticals Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=13.176/115.1156*115.1156
=13.176

Current CPI (Mar. 2025) = 115.1156.

Betta Pharmaceuticals Co Quarterly Data

Book Value per Share CPI Adj_Book
201312 2.062 97.624 2.431
201412 1.487 99.000 1.729
201512 2.468 100.600 2.824
201603 0.000 102.200 0.000
201606 3.065 101.400 3.480
201609 2.993 102.400 3.365
201612 4.799 102.600 5.384
201703 4.985 103.200 5.561
201706 4.965 103.100 5.544
201709 5.113 104.100 5.654
201712 5.117 104.500 5.637
201803 5.200 105.300 5.685
201806 5.158 104.900 5.660
201809 5.393 106.600 5.824
201812 5.562 106.500 6.012
201903 5.595 107.700 5.980
201906 5.596 107.700 5.981
201909 5.912 109.800 6.198
201912 6.136 111.200 6.352
202003 6.517 112.300 6.680
202006 6.376 110.400 6.648
202009 7.420 111.700 7.647
202012 10.023 111.500 10.348
202103 10.339 112.662 10.564
202106 10.558 111.769 10.874
202109 10.890 112.215 11.171
202112 10.980 113.108 11.175
202203 11.247 114.335 11.324
202206 11.296 114.558 11.351
202209 11.573 115.339 11.551
202212 11.615 115.116 11.615
202303 11.722 115.116 11.722
202306 12.109 114.558 12.168
202309 12.533 115.339 12.509
202312 12.548 114.781 12.585
202403 13.196 115.227 13.183
202406 13.075 114.781 13.113
202409 13.470 115.785 13.392
202412 13.319 114.893 13.345
202503 13.176 115.116 13.176

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Betta Pharmaceuticals Co  (SZSE:300558) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Betta Pharmaceuticals Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Betta Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 355, Xingzhong Road, Economic and Technological Development Zone, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311100
Betta Pharmaceuticals Co Ltd is a pharmaceutical enterprise that focuses on the research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates in China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co Headlines

No Headlines